Gag-specific immune responses after immunization with p17/p24:Ty virus-like particles in HIV type 1-seropositive individuals.
暂无分享,去创建一个
J. Veenstra | F. de Wolf | M. Klein | M. Roos | R. Coutinho | G. Patou | F. Miedema | I. Gow | A. M. Holwerda
[1] I. Williams,et al. Immunization with recombinant p17/p24:Ty virus-like particles in human immunodeficiency virus-infected persons. , 1996, The Journal of infectious diseases.
[2] F. Miedema,et al. Fine-specificity of cytotoxic T lymphocytes which recognize conserved epitopes of the Gag protein of human immunodeficiency virus type 1. , 1996, The Journal of general virology.
[3] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[4] T. Elbeik,et al. Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.
[5] A. Namazi,et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination , 1995 .
[6] S. Rowland-Jones,et al. Immune responses in HIV-exposed seronegatives: have they repelled the virus? , 1995, Current opinion in immunology.
[7] I. Thior,et al. Natural protection against HIV-1 infection provided by HIV-2. , 1995, Science.
[8] A. Mazzone,et al. HIV‐specific lymphoproliferative responses in asymptomatic HIV‐infected individuals , 1995, Clinical and experimental immunology.
[9] H. Schuitemaker,et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics , 1995, The Journal of experimental medicine.
[10] S. Rowland-Jones,et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women , 1995, Nature Medicine.
[11] M. Roos,et al. T cell function in vitro is an independent progression marker for AIDS in human immunodeficiency virus-infected asymptomatic subjects. , 1995, The Journal of infectious diseases.
[12] S. Mento,et al. Cytotoxic T‐lymphocyte induction in asymptomatic HIV‐1‐infected patients immunized with Retrovector®‐transduced autologous fibroblasts expressing HIV‐1IIIB Env/Rev proteins , 1995, AIDS.
[13] R. Siliciano,et al. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. , 1994, AIDS research and human retroviruses.
[14] J. Sninsky,et al. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection , 1994, Journal of clinical microbiology.
[15] Seamus J. Martin,et al. Immunization of human HIV‐seronegative volunteers with recombinant p17/p24: Ty virus‐like particles elicits HIV‐1 p24‐specific cellular and humoral immune responses , 1993, AIDS.
[16] A. Kingsman,et al. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. , 1993, Journal of immunology.
[17] D. van Strijp,et al. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. , 1993, Journal of virological methods.
[18] F. Miedema,et al. Selective in vitro expansion of HLA class I‐restricted HIV‐1 Gag‐specific CD8 + T cells: cytotoxic T‐lymphocyte epitopes and precursor frequencies , 1993, AIDS.
[19] D. Katzenstein,et al. Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Kingsman,et al. Enhanced proliferative cellular responses to HIV-1 V3 peptide and gp120 following immunization with V3:Ty virus-like particles. , 1992, Immunology.
[21] R. Coutinho,et al. HIV‐1 biological phenotype in long‐term infected individuals evaluated with an MT‐2 cocultivation assay , 1992, AIDS.
[22] A. Kingsman,et al. HIV p24-specific helper T cell clones from immunized primates recognize highly conserved regions of HIV-1. , 1990, Journal of immunology.
[23] J. Berzofsky,et al. Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals , 1989, Nature.
[24] K. Steimer,et al. Lymphocyte proliferative responses to human immunodeficiency virus antigens in vitro. , 1989, The Journal of clinical investigation.
[25] M. Kieny,et al. HIV-1 core proteins expressed from recombinant vaccinia viruses. , 1989, AIDS research and human retroviruses.
[26] A. Kingsman,et al. The expression of hybrid HIV:Ty virus-like particles in yeast , 1987, Nature.
[27] B. Walker,et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals , 1987, Nature.
[28] W A Buurman,et al. Limiting dilution assays. Experimental design and statistical analysis. , 1987, Journal of immunological methods.